Molecular Templates Q2 2024 GAAP EPS $(1.23) Beats $(1.44) Estimate, Sales $572.00K Beat $430.00K Estimate
Portfolio Pulse from Benzinga Newsdesk
Molecular Templates (NASDAQ:MTEM) reported Q2 2024 GAAP EPS of $(1.23), beating the $(1.44) estimate. Sales were $572K, surpassing the $430K estimate but down 91.67% from $6.87M last year.
August 14, 2024 | 8:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Molecular Templates (NASDAQ:MTEM) reported better-than-expected Q2 2024 GAAP EPS of $(1.23) and sales of $572K, beating estimates but showing a significant YoY decline in revenue.
MTEM's better-than-expected EPS and sales figures are positive short-term indicators, despite the significant YoY revenue decline. The market may react favorably to the earnings beat.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100